Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.22 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.128SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.405SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.296SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.421SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.364SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.82SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.251SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BL.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BS.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.256SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.248SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.70SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.559SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.406SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.69SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.640SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.43.6 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBF.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.43.9 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XUSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.372SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.425SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.144SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.132 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDGSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used